Wastewater monitoring data from the Centers for Disease Control and Prevention (CDC) indicate an uptick in COVID-19 activity across several states, particularly in the South and on the West Coast. While overall national levels remain low, health experts noted that Missouri and Alaska are currently reporting moderate levels of the virus. Dr. Susan Kline of the University of Minnesota stated that wastewater testing has become a primary method for tracking these trends due to a decrease in clinical testing and at-home reporting.
Public health officials observed that the current increase aligns with a predictable seasonal pattern seen in previous years, where cases often begin to rise in August following a low point in early summer. Dr. Neil Maniar of Northeastern University attributed the trend to a combination of factors, including increased summer travel and low vaccination rates. CDC data shows that 17.5% of U.S. adults and 8.9% of children received the 2025-2026 COVID-19 vaccine.
The U.S. Food and Drug Administration (FDA) has directed manufacturers to update the COVID-19 vaccine formula to better match currently circulating strains for the 2026-2027 season. These updated shots are expected to be available in the fall. Experts suggested that while high-risk individuals might consider a second dose of the current vaccine now, most people should wait for the new formulation. Alongside the COVID-19 uptick, health officials also noted a significant surge in measles cases across the country.
For the average household, this development indicates a likely change in health recommendations regarding masking and social distancing in crowded areas like airports or public transit during the remainder of the summer. Those who test positive may still access treatments such as Paxlovid to reduce recovery time, provided they seek care shortly after symptoms appear. The current data suggests that the virus continues to follow a twice-yearly cycle, with peaks typically occurring in late summer and again in late December or early January.
The broader public health infrastructure is currently managing simultaneous increases in multiple respiratory and vaccine-preventable illnesses. The upcoming fall season will mark a critical period for health providers as they coordinate the rollout of the new 2026-2027 COVID-19 vaccine alongside annual flu shots. The CDC and FDA have not yet released the specific effective date for the new vaccine, but officials have indicated a target window of September or October 2026 for public availability.